The Challenge
A health data company needed to build a real-world evidence platform for pharmaceutical research. We implemented Databricks with OMOP CDM and automated de-identification — processing 50M patient records with FDA-ready analytical output. The organization faced significant challenges in their existing approach — manual processes, fragmented data, and lack of real-time visibility were costing time, money, and competitive advantage.
The leadership team had attempted to address this before. Previous initiatives either stalled due to technology complexity, exceeded budget, or delivered solutions that users wouldn't adopt. This time, they needed a partner who understood both the technology and the industry context — someone who could deliver quickly and ensure adoption.
The specific pain points were clear: existing systems couldn't scale, reporting was always retrospective (showing last month's data when today's decisions were needed), and the technical team lacked the specialized skills required for modern data engineering solutions. Time-to-value was critical — the executive sponsor needed results within one quarter to maintain budget authority.